Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001082568 | SCV000290763 | benign | Parathyroid carcinoma | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589443 | SCV000699509 | benign | not provided | 2016-04-28 | criteria provided, single submitter | clinical testing | Variant summary: The c.1185A>G in CDC73 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 splice-site tools in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.16%, predominantly in individuals of African descent (1.7%), including one homozygote. The observed frequency greatly exceeds the maximum expected allele frequency for a pathogenic variant of 0.00041%, suggesting that it is a benign polymorphism. The variant of interest has been reported polymorphism in published report(s) (Newey, 2010). Taken together, based on the prevalence in general population the variant was classified as Benign. |
Ambry Genetics | RCV001010209 | SCV001170368 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001099297 | SCV001255740 | likely benign | Hyperparathyroidism 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001082568 | SCV001255741 | benign | Parathyroid carcinoma | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV001099298 | SCV001255742 | benign | Hyperparathyroidism 2 with jaw tumors | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000589443 | SCV001751466 | benign | not provided | 2018-09-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20052758) |
Genetic Services Laboratory, |
RCV001820766 | SCV002066375 | benign | not specified | 2021-04-02 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001099298 | SCV004016989 | benign | Hyperparathyroidism 2 with jaw tumors | 2023-07-07 | criteria provided, single submitter | clinical testing |